Challenges Face Wuxi Lung Cancer Prevention and Treatment Industry Conference

Top of mind during the Conference on 13 January and co-organised by AstraZeneca China was the requirement by 2030 for the overall 5-year cancer survival rate is to reach 46.6 percent. Full story (in Chinese) via this link; read the absolute essentials about Wuxi via this link.